Podcasts > Archived Podcasts > Market Foolery
This show is no longer producing new episodes. Check out our other shows.
Market Foolery
The Lollipop War Has Begun
Mar 21, 2019 (17:51)
Biogen falls 30% after halting trials for its Alzheimer’s drug. Healthcare analyst (and Industry Focus host) Shannon Jones discusses potential next moves for the suddenly-embattled pharmaceutical company. CVS starts selling cannabis products in eight states. Plus, a federal judge sides with the maker of Dum Dum lollipops in a battle against Tootsie Roll.
Get $50 off your first job post at http://www.LinkedIn.com/Fool">www.LinkedIn.com/Fool.
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.